L2 Asset Management’s Quest Diagnostics DGX Stock Holding History

L2 Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,347	Closed	-$1.89M	–	162
2023 Q1	$1.89M	Buy	13,347 +7,919	+146%	+$1.13M	1.04%	29
2022 Q4	$849K	Buy	5,428 +30	+0.6%	+$4.31K	0.53%	58
2022 Q3	$662K	Buy	5,398 +688	+15%	+$90.6K	0.46%	62
2022 Q2	$626K	Buy	4,710 +466	+11%	+$63.5K	0.45%	65
2022 Q1	$581K	Buy	+4,244	New	+$592K	0.33%	81

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

L2 Asset Management's DGX Position: Q2 2023 in Review

L2 Asset Management sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 13,347 shares — an estimated $1.89M sold.

L2 Asset Management first reported a position in DGX in Q1 2022 and held it in 5 quarters. The position peaked at $1.89M in Q1 2023. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

L2 Asset Management reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
L2 Asset Management sold 13,347 Quest Diagnostics shares in Q2 2023, an estimated $1.89M.
L2 Asset Management first reported a position in Quest Diagnostics in Q1 2022 and held it in 5 quarters.
L2 Asset Management's Quest Diagnostics position peaked at $1.89M in Q1 2023.
818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on L2 Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.